Search
for
Sort by
Research 481–510 of 1000+
- 14 viviendas unifamiliares adosadas: Urbanización Lares. Avda. Burgos. Logroño
- SYMPTOMATOLOGY AND TREATMENT OF COVID-19 AFFECTING SKIN APPENDAGES: A NARRATIVE REVIEW BEYOND COVID-TOES.
- Is there a link between androgenetic alopecia and COVID-19?
- 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Finding Long-COVID: Temporal Topic Modeling of Electronic Health Records from the N3C and RECOVER Programs
- The effect of low-level laser therapy on severe acute respiratory syndrome coronavirus-2 infected cells
- Abnormal Saccadic Oscillations Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Encephalopathy and Ataxia
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility
- 068 Association of systemic involvement with skin morphology assessed by multiphoton microscopy in pseudoxanthoma elasticum
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- Pathogenesis, Clinical Manifestations and Laboratory Findings of the COVID-19
- A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Relationship Between the Route of Transmission, Environmental Tolerance and Mutation Rate of Some RNA Viruses with Their Pathogenicity
- Severe Acute Respiratory Syndrome (SARS)
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
- Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
- Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Pharmacological Activity of Cepharanthine